{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:27:58Z","timestamp":1792729678721,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012486","name":"Innovation-Driven Project of Central South University","doi-asserted-by":"publisher","award":["2023ZZTS0554"],"award-info":[{"award-number":["2023ZZTS0554"]}],"id":[{"id":"10.13039\/501100012486","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012476","name":"Fundamental Research Funds for Central Universities of the Central South University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2020JJ5505"],"award-info":[{"award-number":["2020JJ5505"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.biopha.2024.116613","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T23:09:22Z","timestamp":1713827362000},"page":"116613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Protective role of hydrogen sulfide against diabetic cardiomyopathy by inhibiting pyroptosis and myocardial fibrosis"],"prefix":"10.1016","volume":"175","author":[{"given":"Maojun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biopha.2024.116613_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10741-018-9749-1","article-title":"Diabetic cardiomyopathy: molecular mechanisms, detrimental effects of conventional treatment, and beneficial effects of natural therapy","volume":"24","author":"Parim","year":"2019","journal-title":"Heart Fail Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116613_bib2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.tcm.2019.12.010","article-title":"Antihyperglycemic therapies and cardiovascular outcomes in patients with type 2 diabetes mellitus: State of the art and future directions","volume":"31","author":"Kato","year":"2021","journal-title":"Trends Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.biopha.2024.116613_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116613_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy - a comprehensive updated review","volume":"62","author":"Murtaza","year":"2019","journal-title":"Prog. Cardiovasc Dis."},{"issue":"1","key":"10.1016\/j.biopha.2024.116613_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1152\/physrev.00028.2021","article-title":"Physiological roles of hydrogen sulfide in mammalian cells, tissues, and organs","volume":"103","author":"Cirino","year":"2023","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2024.116613_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41569-022-00741-6","article-title":"Sulfide regulation of cardiovascular function in health and disease","volume":"20","author":"Kolluru","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116613_bib7","first-page":"1867","article-title":"Hydrogen sulfide attenuates myocardial fibrosis in diabetic rats through the JAK\/STAT signaling pathway","volume":"41","author":"Liu","year":"2018","journal-title":"Int J. Mol. Med"},{"key":"10.1016\/j.biopha.2024.116613_bib8","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fphar.2020.01150","article-title":"Exogenous Hydrogen Sulfide Ameliorates Diabetic Myocardial Fibrosis by Inhibiting Cell Aging Through SIRT6\/AMPK Autophagy","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2024.116613_bib9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: Gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.biopha.2024.116613_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2022.07.005","article-title":"Current knowledge of pyroptosis in heart diseases","volume":"171","author":"Gao","year":"2022","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2024.116613_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.791848","article-title":"Pyroptosis and Its Regulation in Diabetic Cardiomyopathy","volume":"12","author":"Lu","year":"2022","journal-title":"Front Physiol."},{"key":"10.1016\/j.biopha.2024.116613_bib12","article-title":"Potential therapeutic role of pyroptosis mediated by the NLRP3 inflammasome in type 2 diabetes and its complications","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.biopha.2024.116613_bib13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fphys.2020.00381","article-title":"Chemerin\/CMKLR1 Axis Promotes inflammation and pyroptosis by activating nlrp3 inflammasome in diabetic cardiomyopathy rat","volume":"11","author":"Xie","year":"2020","journal-title":"Front Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2024.116613_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.biopha.2024.116613_bib15","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res"},{"issue":"4","key":"10.1016\/j.biopha.2024.116613_bib16","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-17-0724","article-title":"MECHANISMS IN ENDOCRINOLOGY: Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review","volume":"178","author":"Levelt","year":"2018","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"10.1016\/j.biopha.2024.116613_bib17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.biopha.2024.116613_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/antiox10060910","article-title":"Modulation of EndMT by Hydrogen Sulfide in the Prevention of Cardiovascular Fibrosis","volume":"10","author":"Testai","year":"2021","journal-title":"Antioxid. (Basel)"},{"issue":"13","key":"10.1016\/j.biopha.2024.116613_bib19","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1021\/acs.analchem.2c03640","article-title":"Evaluating the Effect of Hydrogen Sulfide in the Idiopathic Pulmonary Fibrosis Model with a Fluorescent Probe","volume":"95","author":"Hou","year":"2023","journal-title":"Anal. Chem."},{"issue":"10","key":"10.1016\/j.biopha.2024.116613_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5483\/BMBRep.2022.55.10.124","article-title":"Function of gaseous hydrogen sulfide in liver fibrosis","volume":"55","author":"Lee","year":"2022","journal-title":"BMB Rep."},{"issue":"23","key":"10.1016\/j.biopha.2024.116613_bib21","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1097\/CM9.0000000000000537","article-title":"Involvement of hydrogen sulfide in the progression of renal fibrosis","volume":"132","author":"Wang","year":"2019","journal-title":"Chin. Med J. (Engl. )"},{"key":"10.1016\/j.biopha.2024.116613_bib22","article-title":"Hydrogen Sulfide Plays an Important Role in Diabetic Cardiomyopathy","volume":"9","author":"Zhao","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.biopha.2024.116613_bib23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.freeradbiomed.2022.01.028","article-title":"Protective role of hydrogen sulfide against diabetic cardiomyopathy via alleviating necroptosis","volume":"181","author":"Gong","year":"2022","journal-title":"Free Radic. Biol. Med"},{"issue":"11","key":"10.1016\/j.biopha.2024.116613_bib24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic Mechanisms of Diabetic Heart Disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res"},{"issue":"5","key":"10.1016\/j.biopha.2024.116613_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tips.2018.02.010","article-title":"Emerging actors in diabetic cardiomyopathy: heartbreaker biomarkers or therapeutic targets?","volume":"39","author":"Palomer","year":"2018","journal-title":"Trends Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2024.116613_bib26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/CIRCRESAHA.118.311371","article-title":"Heart failure in type 2 diabetes mellitus","volume":"124","author":"Kenny","year":"2019","journal-title":"Circ. Res."},{"issue":"11","key":"10.1016\/j.biopha.2024.116613_bib27","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3390\/antiox9111038","article-title":"The protective role of hydrogen sulfide against obesity-associated cellular stress in blood glucose regulation","volume":"9","author":"Mezouari","year":"2020","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.biopha.2024.116613_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.842313","article-title":"Pyroptosis-related inflammasome pathway: a new therapeutic target for diabetic cardiomyopathy","volume":"13","author":"Cai","year":"2022","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2024.116613_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41392-022-01306-2","article-title":"CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.biopha.2024.116613_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41419-021-04484-z","article-title":"METTL14 suppresses pyroptosis and diabetic cardiomyopathy by downregulating TINCR lncRNA","volume":"13","author":"Meng","year":"2022","journal-title":"Cell Death Dis."},{"issue":"10","key":"10.1016\/j.biopha.2024.116613_bib31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","article-title":"Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.biopha.2024.116613_bib32","doi-asserted-by":"crossref","first-page":"10632","DOI":"10.3390\/ijms231810632","article-title":"NLRP3 Inflammasome\/pyroptosis: a key driving force in diabetic cardiomyopathy","volume":"23","author":"Zhang","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.biopha.2024.116613_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2024.116613_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/1535370219899899","article-title":"Hydrogen sulfide mitigates myocardial inflammation by inhibiting nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation in diabetic rats","volume":"245","author":"Jia","year":"2020","journal-title":"Exp. Biol. Med (Maywood)"},{"issue":"12","key":"10.1016\/j.biopha.2024.116613_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166497","article-title":"GYY4137 ameliorates sepsis-induced cardiomyopathy via NLRP3 pathway","volume":"1868","author":"Zhou","year":"2022","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"14","key":"10.1016\/j.biopha.2024.116613_bib36","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.7150\/ijbs.47595","article-title":"Hydrogen Sulfide Plays an Important Role by Influencing NLRP3 inflammasome","volume":"16","author":"Wang","year":"2020","journal-title":"Int J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2024.116613_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41419-017-0257-3","article-title":"Nicotine promotes atherosclerosis via ROS-NLRP3-mediated endothelial cell pyroptosis","volume":"9","author":"Wu","year":"2018","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.biopha.2024.116613_bib38","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/cells9091948","article-title":"Loganin Attenuates High Glucose-Induced Schwann Cells Pyroptosis by Inhibiting ROS Generation and NLRP3 Inflammasome Activation","volume":"9","author":"Cheng","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2024.116613_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.freeradbiomed.2022.02.027","article-title":"Silica nanoparticles induce pyroptosis and cardiac hypertrophy via ROS\/NLRP3\/Caspase-1 pathway","volume":"182","author":"Wang","year":"2022","journal-title":"Free Radic. Biol. Med"},{"key":"10.1016\/j.biopha.2024.116613_bib40","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8908960","article-title":"Hydrogen sulfide attenuates high glucose-induced human retinal pigment epithelial cell inflammation by inhibiting ROS formation and NLRP3 inflammasome activation","volume":"2019","author":"Wang","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.biopha.2024.116613_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.freeradbiomed.2019.04.025","article-title":"Hydrogen sulfide protects against DSS-induced colitis by inhibiting NLRP3 inflammasome","volume":"137","author":"Qin","year":"2019","journal-title":"Free Radic. Biol. Med"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224004979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:38:02Z","timestamp":1778693882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224004979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":41,"alternative-id":["S0753332224004979"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116613","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective role of hydrogen sulfide against diabetic cardiomyopathy by inhibiting pyroptosis and myocardial fibrosis","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116613"}}